Skip to main navigation Skip to search Skip to main content

Non-invasive telemonitoring in heart failure: A systematic review

  • Patrick A. Kwaah
  • , Emmanuel Olumuyide
  • , Kassem Farhat
  • , Barbara Malaga-Espinoza
  • , Ahmed Abdullah
  • , Michael H. Beasley
  • , Novi Y. Sari
  • , Lily K. Stern
  • , Julio A. Lamprea-Montealegre
  • , Adrian daSilva-deAbreu
  • , Jiun-Ruey Hu
  • Department of Internal Medicine, Yale School of Medicine, Waterbury, CT 06708, USA.
  • Department of Internal Medicine, School of Medicine, University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
  • Department of Internal Medicine, Griffin Hospital, Derby, CT 06418, USA.
  • Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
  • Siloam Heart Institute, Siloam Hospitals Kebon Jeruk, Jakarta 11530, Indonesia.
  • Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Division of Cardiology, Department of Medicine, University of California, San Francisco, CA 94143, USA.
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Research output: Contribution to journal › Review article › peer-review

Abstract

Background and Objectives: Heart failure (HF) represents a major public health challenge worldwide, with rising prevalence, high morbidity and mortality rates, and substantial healthcare costs. Non-invasive telemonitoring has emerged as a promising adjunct in HF management, yet its clinical effectiveness remains unclear.

Materials and Methods: In this systematic review, we summarize randomized controlled trials (RCTs) between 2004 and 2024 examining the efficacy of non-invasive telemonitoring on mortality, readmission, and quality of life (QoL) in HF. In addition, we characterize the heterogeneity of features of different telemonitoring interventions.

Results: In total, 32 RCTs were included, comprising 13,294 participants. While some individual studies reported benefits, non-invasive telemonitoring demonstrated mixed effects on mortality, readmission rates, and QoL. The most common modality for interfacing with patients was by mobile application (53%), followed by web portals (22%), and stand-alone devices (19%). Periodic feedback (63%) was more common than continuous feedback (31%) or on-demand feedback (6%). Clinician reviews of patient telemonitoring data was event-triggered (44%) more commonly than based on a prespecified timeline (38%). In most designs (90%), patients played a passive role in telemonitoring.

Conclusions: Non-invasive telemonitoring interventions for HF exhibited considerable variation in duration and system design and had a low rate of patient engagement. Future work should focus on identifying telemonitoring-responsive subgroups and refining telemonitoring strategies to complement traditional HF care.

Original languageAmerican English
Article number1277
JournalMedicina (Kaunas, Lithuania)
Volume61
Issue number7
DOIs
StatusPublished - Jul 15 2025

ASJC Scopus Subject Areas

  • General Medicine

Keywords

  • heart failure
  • mortality
  • quality of life
  • readmission
  • telemonitoring

Cite this